drugset / Trial / NCT04488601
Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity Study
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This is a randomized, placebo-controlled trial into the safety and efficacy in reducing clinical measures of aging in an older adult population.
Timeline
- Start
- 2020-01-01
- Primary completion
- 2023-12-30
- Completion
- 2023-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rapamycin | Small molecule | 5 mg | — |
| Subject | Rapamycin | Small molecule | 10 mg | — |